LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. LifeScienceXchange multiplies the impact of biologics and immunotherapy R&D, bringing new treatments to patients faster.

Latest News and Commentary

Top 25 of ’25: NextGen Biomed eBook

Top 25 of ’25: NextGen Biomed eBook

Curated insight from the leaders shaping biologics and immunotherapy
News
Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Tom Cohen Digital Publisher, Oxford Global
News
Three Innovations for Green and Controlled Peptide Manufacture
Technology Spotlight PolyPeptide Group

Three Innovations for Green and Controlled Peptide Manufacture

Fabien Rousset Director Global Innovation, PolyPeptide
Technology Spotlight
Peptides
Market Insight

The Digital Transformation of Oligonuleotide Development

Martin Olbrich Principal Scientist, Process Research, Roche
Market Insight
Oligonucleotides
Market Insight

Targeting Melanoma with the SCIB1 Vaccine

Samantha Paston Head of Translational Research, Scancell
Market Insight
Vaccines
NGB LSX - Connect with Peers

Latest Technology Spotlights
Interview with Nicola Bonzanni

Interview with Nicola Bonzanni

Proteins, Antibodies & ADCs
Apr, 2026
Interview with Alastair Hay, Vice President of Peptides, Almac

Interview with Alastair Hay, Vice President of Peptides, Almac

Peptides
Apr, 2026
Interview with Stef van Grieken, Co-Founder and Chief Executive Officer, Cradle

Interview with Stef van Grieken, Co-Founder and Chief Executive Officer, Cradle

Proteins, Antibodies & ADCs
Apr, 2026
Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor

Interview with Mingjie Xie, Chief Executive Officer, Rapid Novor

Proteins, Antibodies & ADCs
Apr, 2026

Latest News

See all
Interview with Denise Steckel

Interview with Denise Steckel

Apr, 2026
Interview with Ilse Roodink, CSO, AVS Bio

Interview with Ilse Roodink, CSO, AVS Bio

Apr, 2026
Interview with Nick Challoner, CEO, Ingenza

Interview with Nick Challoner, CEO, Ingenza

Apr, 2026

Thought Leadership
Early Regulatory Strategy Is Critical for Immunotherapy Development

Early Regulatory Strategy Is Critical for Immunotherapy Development

Livija Deban Chief Scientific Officer, Prokarium
Callum Scott Senior Vice President, Development, Scancell
Margareth Jorvid Senior Partner, LSM Group / Life Science Management
Proteins, Antibodies & ADCs
Jul, 2026
Interview with Hans Melo

Interview with Hans Melo

Hans Melo Co-Founder & Chief Executive Officer, Menten AI
Peptides
Mar, 2026
Interview with Karen Silence

Interview with Karen Silence

Karen Silence Vice President, argenx
Proteins, Antibodies & ADCs
Mar, 2026

Market Insight: Across Modalities

An All Stakeholder Approach To Cell & Gene Therapy

Cell & Gene
Nov, 2025

Scaling Up Complex Organoid Models: Challenges And Solutions

Cell & Gene
Nov, 2025

Challenges and Solutions in the Purification of Oligonucleotides

Oligonucleotides
Apr, 2025

Protein Corona and Freeze-Thaw Stability in Lipid Nanoparticles

Oligonucleotides
Apr, 2025

Pre-Clinical Considerations For Development Of ADCs

Proteins, Antibodies & ADCs
Oct, 2025

How ‘Proximity Medicines’ Are Transforming Pharmacotherapy

Proteins, Antibodies & ADCs
Oct, 2025

Snakebite Medicines: Venom Derived Peptides for Therapeutic Indications

Peptides
May, 2025

AI-Powered Peptide Design: Transforming Drug Discovery with Machine Learning

Peptides
May, 2025

Cell-Free Cancer Vaccines Developed in Two Weeks

Vaccines
May, 2025

Potency Testing in RNA Therapeutics

Vaccines
May, 2025

You're just a click away

To access our site, please accept the Terms of Use - our full terms of use are available below.
Full Terms of Use

By rejecting you won't be able to progress to the LifeScienceXchange platform.